# BOOSTRIX

NDC: 50090-1831
Generic name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
Labeler / Manufacturer: A-S Medication Solutions
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAMUSCULAR
Marketing started: 20090724

FDA application: BLA125106

## Active ingredients

- BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 8 ug/.5mL
- BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 ug/.5mL
- BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED): 8 ug/.5mL
- CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [iU]/.5mL
- CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 [iU]/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-1831"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-1831